Resource Library

Case Study Clinical Obesity Management Vida’s holistic care model and relationships with major PBMs allow us to support high-value coverage strategies in ways others can’t. Having already launched several clients this year, we have real results to share — like how only 9% of members started on GLP-1s with our preferred prescriber program, as opposed […]

Dr. Fatima Cody Stanford, Associate Professor of Medicine at Harvard Medical School, and Dr. Richard Frank, Vida’s Chief Medical Officer, discuss implementing a virtual obesity center of excellence to meet this disease head-on.

Organizations are inundated with obesity solutions, and uncovering the actual clinical impact of an individual solution can be difficult. How can organizations know what to look for when evaluating solutions?

Guide The 5 Myths of Obesity Management As new information comes out about how best to treat obesity, it can be hard to get to the bottom of what really matters for outcomes — and costs. Read our guide to learn:

How do we best address the issue at its root and develop holistic solutions to tackle the broader aspects of well-being?

Corporate jargon is full of acronyms for vague and aspirational concepts. Healthcare is even worse. Parsing the terms can help.

Some of the largest organizations in the US spend upwards of $16,000 per person per year on costs associated with GLP-1s. How much are you willing to spend on GLP-1s annually? Learn about how GLP-1 and other anti-obesity medications can be properly managed without costly lifetime prescriptions.

How does Vida’s care delivery perform in different SDOH settings?

How to get obesity outcomes without breaking the bank Obesity isn’t a cosmetic condition. It’s a serious disease that gravely impacts over 42% of Americans. It’s a leading risk factor for diabetes, heart disease, stroke, high blood pressure, liver and kidney disease, reproductive issues, and many types of cancer. Those conditions cost upwards of $500 billion a year in US healthcare […]

Learn more from this retrospective study examining the relationship between improvements in glycemic control as a result of a digital health intervention and the food environment.

The confusion around obesity management doesn’t help dispel the myths and stigmas. Despite it all, one thing is clear: obesity is a complex and highly-individualized disease that impacts millions of Americans. And it’s only getting worse.

What role should medications play in treating obesity? In this webinar Obesity expert Dr. Fatima Cody and Vida’s Chief Medical Officer Dr. Richard Frank discuss.